Everence Capital Management’s Magellan Health Services, Inc. MGLN Stock Holding History

Everence Capital Management’s Portfolio MGLN Stock Details MGLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,370	Closed	-$415K	–	802
2021 Q4	$415K	Hold	4,370	–	–	0.03%	490
2021 Q3	$413K	Hold	4,370	–	–	0.03%	458
2021 Q2	$412K	Hold	4,370	–	–	0.03%	456
2021 Q1	$407K	Sell	4,370 -1,210	-22%	-$113K	0.04%	440
2020 Q4	$462K	Hold	5,580	–	–	0.05%	362
2020 Q3	$423K	Hold	5,580	–	–	0.05%	352
2020 Q2	$418K	Buy	+5,580	New	+$357K	0.05%	349
2020 Q1	–	Sell	-3,260	Closed	-$255K	–	699
2019 Q4	$255K	Hold	3,260	–	–	0.04%	536
2019 Q3	$202K	Hold	3,260	–	–	0.03%	575
2019 Q2	$242K	Hold	3,260	–	–	0.04%	492
2019 Q1	$215K	Buy	+3,260	New	+$209K	0.04%	525

Everence Capital Management's MGLN Position: Q1 2022 in Review

Everence Capital Management sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 4,370 shares — an estimated $415K sold.

Everence Capital Management first reported a position in MGLN in Q1 2019 and held it in 11 quarters. The position peaked at $462K in Q4 2020. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

Everence Capital Management reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
Everence Capital Management sold 4,370 Magellan Health Services, Inc. shares in Q1 2022, an estimated $415K.
Everence Capital Management first reported a position in Magellan Health Services, Inc. in Q1 2019 and held it in 11 quarters.
Everence Capital Management's Magellan Health Services, Inc. position peaked at $462K in Q4 2020.
0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on Everence Capital Management's 13F filing for Q1 2022, filed 11 Apr 2022.